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ABSTRACT 
Pterygium is an old challenge for ophthalmic surgeons. Its final resolution is surgical intervention. New surgical 
techniques have been introduced to improve the outcome, however, the possibility of recurrence always exists. The 
purpose of this study was to evaluate the pterygium recurrence rate with a long-term follow-up, after surgery was 
performed with conjunctival autograft and fibrin glue as a biological adhesive. A retrospective case-series study was 
performed, reviewing cases operated from May 2008 to May 2018 with at least 1 year of follow-up in a private clinic in 
Buenos Aires, Argentina. The evaluation time-points were at 1 day, 20 days, 6 months, 1 year after surgery and then 
every year. All the procedures were performed by the same surgeon in single center. Topical Mitomycin C (MMC), 5-
Fluorouracil (5-FU), cauterization and/or amniotic membrane were not used in any case. From a total of 159 operated 
eyes (82/77 women/men), pterygium was recurred in 7 eyes (4.4%); all of them detected at the second follow-up time-
point (at day 20). Intraoperative complications did not occur, but at the postoperative stage, one case presented a 
conjunctival granuloma, which was surgically resolved. In conclusion, a low pterygium recurrence rate was observed 
after conjunctival autograft with fibrin glue. In our study, recurrence was found at the postoperative first month and did 
not recur until the end of follow-up for 10 years. 
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INTRODUCTION
The cornea must be clear to let the light get into the eye 
and the visual process begins. When the cornea loses its 
transparency, the sight could be severely affected, as 
happens when pterygium grows and covers the pupillary 
axis [1-3]. Patients with pterygium consult physicians 
because of discomfort, ocular surface inflammation, red 
eyes, (aesthetic reasons) or finally, when their vision is 
decreased [4, 5]. Different hypotheses exist about the 
pterygium pathogenesis and its progression [6-9]. 
However, the final decision is surgery. It seems to be 
easy, but usually its complexity is underestimated. 
Patients feel pain during and after the procedure, the 
conjunctiva bleeds and with traditional techniques, 
several conjunctival sutures must be performed and the 
most frustrating situation is when the pterygium recurs. 
Pterygium is an old challenge for ophthalmic surgeons, 
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therefore, new surgical techniques have been introduced 
to improve its result, however, the possibility of 
recurrence always exists [5, 10-15]. To reduce recurrence 
rates with fewer complications, pterygium excision 
performed with conjunctival autografting seems to be 
the best surgical procedure [5, 12, 13]. Actually, the 
possibility to perform a sutureless surgery using 
biological adhesive, decreases the operation time and 
increases patient satisfaction (less pain) [14-21]. Here we 
aimed to evaluate the pterygium recurrence rate with a 
long term follow-up, after the operation was performed 
with conjunctival autograft and fibrin glue. 
METHODS 
Study Design 
A retrospective case-series study was performed, 
reviewing the clinical charts of patients operated due to 
pterygium from May 2008 to May 2018. The surgical 
technique was conjunctival autograft with fibrin glue 
performed by the same surgeon (P.L.D.) in a private clinic 
in Buenos Aires City, Argentina. Topical Mitomycin C 
(MMC), 5-Fluorouracil (5-FU), cauterization, and/or 
amniotic membrane were not used in any case. Exclusion 
criteria were those with less than one year of follow-up. 
The study was conducted in accordance with the 
Declaration of Helsinki and an approval was obtained 
from the “Centro Integral de Salud Visual” Institutional 
Review Board/Ethics Committee. Patients were informed 
about surgical characteristics and their possible risks and 
complications. A written informed consent was obtained 
from all participants.  
Parameters to Evaluate 
Baseline population data (age, gender, and the pterygium 
grade), intra-surgical or post-surgical complications, 
pterygium recurrence rate and years of follow-up were 
evaluated.  
Pterygium was subjectively graded by slit-lamp (Haag-
Streit BI 900; The USA) always by the same observer as 
well as the recurrence rate (defined as any kind of 
fibrous-vascular tissue detected over the limbus, 
invading the cornea). Pterygium was originally graded in 
four stages, based on similar investigations [22, 23] 
according to the presence of fibrous-vascular tissue, from 
nasal limbus to the visual axis, as follows; grade 1 (less 
than 2.0 mm), grade 2 (higher that 2.0 mm and less than 
4.0 mm), grade 3 (higher than 4.00 mm, without covering 
the visual axis) and grade 4 (tissue covering the visual 
axis).  
Routine follow-up time was performed at day 1, day 20, 
month 6 and the first year after the operation and then 
annually till 10 years.  
Surgical Technique (Fig. 1): Topical anesthesia was 
performed with proparacaine 0.5% (Anestalcon®; Alcon) 
and local injection in the head of the pterygium with 
lidocaine/epinephrine preservative free. Firstly, for 
resection of the pterygium body, Westcott scissors was 
used and after that, the fibrovascular corneal tissue was 
resected with crescent, performing a keratotomy to 
completely remove the corneal scarring tissue. The tenon 
was carefully excised and the tissue was remitted to 
posterior anatomopathological evaluation. Then, the 
lower-temporal part of the conjunctiva was marked, to 
obtain the conjunctival graft, resecting the required size 
of tissue to cover the previous excised area. It was 
measured by compass, avoiding to excise the tenon and 
leaving a distance of 2 mm from the sclerocorneal 
limbus. The extracted tissue was everted and placed over 
the cornea and one of the two components from the 
fibrin adhesive was added all over the conjunctival graft 
surface. The receptor zone was dried with a Weck-cel. 
The second component of the fibrin adhesive was added 
over the bare sclera using two 0.12 forceps, the 
conjunctival graft tissue was moved to perform a “bed 
sheet maneuver”, placing the graft over the scleral bed. 
Both conjunctival sides should be placed correctly (one of 
those belong to the limbus side) and completely covering 
the scleral defect. One minute is required to wait until 
both tissues stick together completely. Then, the patient 
was asked to blink several times to confirm the graft 
adherence. Finally, dexamethasone 0.1%/tobramicine 
0.3% (Tobradex® Novartis) topical ointment were 
administered. 
The following treatment was indicated: Mixture of 
gatifloxacin0.3%/prednisolone acetate 1.0% (Zypred®, 
Allergan), every 6 hours, starting one day before the 
operation and then, every 2 hours until two days and 
after that every 6 hours during the next 20 days. 
Ketorolac 0.5% topical drops (Acular®, Allergan), every 8 
hours, starting one day before and after the operation 
for 20 days.  
Topical Mitomycin C (MMC), 5-Fluorouracil (5-FU), 
cauterization, and/or amniotic membrane were not used 
in any case. The adhesive is a commercial substance 
(Beriplast P combi set®; CSL Behring) composed by 
human fibrin, human clotting factor XIII, thrombin, 
aprotinin and calcium chlorure, pasteurized. 
Data was collected in Spreadsheets file (Google; 
https://www.google.com/sheets/about/) and descriptive 
statistics including frequency and percentage were used 
to present the results. 
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RESULTS 
A total of 159 eyes operated were included (82/77 
women/men). Mean ± standard deviation (SD) of age 
was 53.7 ±9.1 years. All of the cases achieved at least one 
year of follow-up. Only 3 cases were operated due to 
recurrent pterygium (which no recurrence later); the rest 
of operations were due to primary pterygium. Pterygium 
was located on the nasal side in all the cases. Follow-up 
time and participants are presented in Table 1. 
The pterygium grade and the percentage are shown in 
Table 2. Most cases 93 (58.5%) had grade 2 of pterygium 
followed by grade 3 in 46 (28.9%) cases, grade 1 in 12 
(7.5%) and grade 4 in 8 (5%). Pterygium recurred in 7 
eyes (4.4%); 4 (2.5%) eyes had pterygium of grade 2 and 
3 (1.9%) grade 3; all of them detected at the second 
follow-up time (day 20). Intraoperative complications did 
not occur postoperatively, except for one case who 
presented a conjunctival granuloma, which was surgically 
resolved. 
 
Figure 1 Video Frames Showing Different Steps Necessary to Excise 
the Pterygium Using Conjunctival Autograft and Fibrin Glue 
 
Table 1. Number of Cases and the Years of Follow-up 
Years of follow-up Number of Cases (Percentage) 
1 11 (6.9) 
2 20 (12.6) 
3 35 (22) 
4 22 (13.8) 
5 15 (9.4) 
6 12 (7.5) 
7 10 (6.3) 
8 14 (8.9) 
9 15 (9.5) 
10 5 (3.1) 
Total of cases 159 (100) 
DISCUSSION 
The present study showed a low recurrence after 
pterygium surgery using conjunctival autograft with fibrin 
glue in long term follow-up. Usually, the complexity of 
pterygium surgery is underestimated. Therefore, new 
surgical techniques for pterygium have been introduced 
to improve its outcome. However, the possibility of 
recurrence is always present.  Kaufman SC et al. in 2013 
indicated that bare sclera excision of pterygium results in 
a higher recurrence rate than excision accompanied by 
the use of certain adjuvants [24]. After that, the use of 
amniotic membrane seemed to be a good choice, but 
Clearfield E et al. compared the safety and effectiveness 
of conjunctival autograft compared to amniotic 
membrane graft and concluded that the pterygium 
excision with conjunctival autograft was associated with 
a lower risk of recurrence at 6 months [25]. A similar 
conclusion has been indicated by different authors [18-
21, 24, 25]. The results of this study also confirm their 
findings. 
 
Table 2. Pterygium Grade and the Recurrence Number Regarding Each 
Grade and the Percentage of Recurrence Rate 
Pterygium grade Eyes 
n (%) 
Recurrence 
n (%) 
Grade 1 12 (7.5) 0 
Grade 2 93 (58.5) 4 (2.5) 
Grade 3 46 (28.9) 3 (1.9) 
Grade 4 8 (5) 0 
Total of eyes 159 (100) 7 (4.4) 
Abbreviations: n: number; %: percentage 
 
Pterygium excision with conjunctival autografting 
reduces recurrence rates with fewer complications, and 
subsequently, has become the first choice of surgical 
procedure. However, a considerable number of 
conjunctival sutures must be performed increasing the 
operation time and postoperative discomfort, which are 
some arguments against this technique. Also, the use of 
sutures in pterygium surgery is associated with 
postoperative inflammation, discomfort and 
complications related to the sutures themselves [5, 18-
21]. 
Since 1944, biological adhesives have been emerged for 
different use in medicine and ophthalmology [16, 17, 24-
28]. For pterygium surgery, their cost could be a 
limitation, however, Gong J et al. compared self-made 
(low-cost) cryopreservative fibrin glue and commercial 
fibrin glue kit in pterygium surgery, concluding that both 
are equally effective [29]. This possibility is interesting, 
especially for countries with economical limitations, but 
unfortunately, it was not evaluated in this series. In the 
present work the biological adhesive used was a 
commercial kit. Most commonly reported complications 
associated to biological adhesive for pterygium surgery in 
the literature include graft dehiscence, graft retraction 
and granuloma [16, 17, 19, 28-31]. In the present series, 
only one case developed conjunctival granuloma which is 
a low rate associated with fibrin glue.  
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The strong point of this study was its long term follow-
up. Also, the results showed that pterygium recurrence 
has occurred at early stages and all of our cases detected 
at the second follow-up time (at day 20). If recurrence 
did not occur during the first postoperative month, 
it did not appear later (or up to ten years follow-up) in 
the present series. This is different from other published 
studies, where pterygium recurrence was detected 
between 6 to 12 months after surgery, using similar 
surgical techniques [15, 21, 22, 30]. 
One of the limitations of the present work was that all 
the operations were performed by the same surgeon 
with more than 30 years of surgical practice. Possibly, a 
learning curve would be necessary to develop this 
technique safety, as could happen with any other surgical 
procedure and good results in part could be associated 
with that [29]. 
Nevertheless, the scientific evidence reported here, 
along 10 years of follow up, shows that this surgical 
method seems to be the most efficient to avoid 
recurrence after pterygium surgery. Cauterization and 
classical adjuvant drugs as 5-FU or MMC usually were 
used to control wound healing and decrease recurrences 
[14]. Nevertheless, secondary to these substances and 
procedures, severe complications could appear [32]. 
herefore, none of these methods was used in the present 
study. This aspect is another issue to remark that the 
results in this series are only associated to the surgical 
technique. New studies are focused on new adjuvants 
therapies, principally with anti-VEGF effect, and some 
results seem to be promising [32-34]. 
It could be interesting to compare the present technique 
with and without anti-VEGF treatment.  
CONCLUSIONS 
In this work, a low recurrence rate after pterygium 
surgery was observed using conjunctival autograft and 
biological adhesive in ten years of follow-up. All the 
recurrences in this study appeared at the postoperative 
first month. There are other aspects not evaluated in this 
study, as patient comfort and surgical time, which are 
probably in favor of this technique as well. Finally, 
multicentric prospective studies could confirm the 
present promising results. 
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